Director, Access Strategy Marketing NSCLC - Remote Eligible

Director, Access Strategy Marketing Nsclc

Remote (United States)

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

The Director, Access Strategy & Marketing will lead the development and execution of access strategy, value proposition development, and execution of marketing materials for the RevMed NSCLC portfolio (daraxonrasib, zoldonrasib and elironrasib). This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc) and channel partners. This role will be instrumental in supporting a successful launch through effective launch planning, tailored messaging to various customer types, and working cross-functionally with Market Access, Brand Marketing, Medical/HEOR, Regulatory and Compliance partners. The ideal candidate will also have experience in translating a dynamic policy and reimbursement landscape into access strategies over the product lifecycle (ie, impact of IRA, MFN, etc).

This position is based out of our headquarters in Redwood City, CA. Remote candidates may be considered on case-by-case basis.

Responsibilities may include:

• Developing and aligning with cross-functional partners on the three-year access strategy across RevMed's NSCLC portfolio.
• Lead the creation of value proposition messaging and materials tailored for payers, PBMs, IDNs, GPOs, channel partners, and other key managed care decision-makers.
• Partner with national account field team to educate on access strategy and available resources.
• Work closely with Brand Marketing, Regulatory and Compliance to ensure all materials support brand goals and follow compliance guidelines.

Required Skills, Experience and Education:

• Bachelor's degree required with 8-10+ years of experience in managed care strategy and marketing.
• Experience in new product launches, including both high level strategy development and tactical execution.
• Strong understanding of access landscape across all market access stakeholders.
• Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
• Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
• Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
• Ability to travel up to 25%.

Preferred Skills:

• 10+ years of experience in Marketing and/or Managed Care.
• Oral Oncolytic product experience strongly preferred.
• Deep understanding of US public policy and reimbursement dynamics.
• Prior experience with developing co-positioning strategy across multiple assets and identifying portfolio tradeoffs.
• Prior experience in customer-facing roles.

Base Pay Salary Range

$201,000 - $251,000 USD